Drugs / Plasmid AMEP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01764009 | Jun 2012 → Dec 2013 | melanoma | Valerio Therapeutics | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plasmid AMEP | “In this open-label, multicentre, dose escalation phase I study, successive cohorts of 3 patients suffering from advanced or metastatic melanoma will be electrotransferred...” NCT01764009 ↗ |
| Known as | AMEP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01764009 ↗ |
| Modality | Other / unclassified | “naked DNA coding for protein AMEP” NCT01764009 ↗ |
| Route | Intramuscular | “intramuscular electrotransferred Plasmid AMEP” NCT01764009 ↗ |